Reference
Ellender CM, et al. Safety of IV amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease. Respirology 21: 357-362, No. 2, Feb 2016. Available from: URL: http://doi.org/10.1111/resp.12676 - Australia
Rights and permissions
About this article
Cite this article
Amikacin. Reactions Weekly 1592, 24 (2016). https://doi.org/10.1007/s40278-016-15452-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-15452-x